NYSE$SLQT
Selectquote Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
SelectQuote reported Q1 2022 results with revenue up 29% year-over-year.
SelectQuote's Q1 2022 revenue increased by 29% year-over-year to $159.9 million. The company reported a net loss of $45.4 million and an adjusted EBITDA of $(44.0) million. The full-year guidance remains unchanged.
- Consolidated revenue increased by 29% year-over-year to $159.9 million.
- Net loss for the quarter was $45.4 million, a decrease of $46.2 million compared to the previous year.
- Adjusted EBITDA was $(44.0) million, compared to $12.1 million in the prior year.
- SelectRx enrollments are now over 7 times higher than at the time of acquisition.
Headline financials
Revenue & EPS history
SelectQuote · Revenue · Quarterly
$160M
Revenue by segment
SelectQuote · $156M total across 2 segments · Q1 2022
- Senior$106M+45.2%68.1%
- Life$49.8M+16.4%31.9%
Forward guidance
SelectQuote began 2022 with strong results that were ahead of internal expectations, and our full year guidance remains unchanged.
Tailwinds
- Strong results that were ahead of internal expectations.
- Full year guidance remains unchanged.
- Early progress of Population Health business.
- SelectRx continues to excel, with daily enrollments now over 7 times higher than the rate of enrollment at the time of our acquisition.
- SelectQuote is very well positioned for another year of strong revenue and EBITDA growth
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-2.4%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+2.2%
Avg return
30 days after
57%
17 / 30 earnings
Positive
+75.5%
Q2 2023
Best reaction
-49.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -8.9% | +39.9% | +24.3% | |
| Q2 2026 | -29.0% | -37.4% | -47.9% | |
| Q1 2026 | +0.0% | -16.8% | -29.3% | |
| Q3 2025 | -12.1% | -14.2% | -15.4% | |
| Q2 2025 | +30.8% | +37.0% | -17.4% | |
| Q1 2025 | +6.9% | +16.7% | +46.1% | |
| Q4 2024 | -49.0% | -44.6% | -37.6% | |
| Q3 2024 | +4.8% | +12.4% | +13.2% | |
| Q2 2024 | +6.3% | +40.5% | +64.0% | |
| Q1 2024 | -4.3% | -5.8% | -3.6% | |
| Q4 2023 | -16.2% | -16.9% | -8.8% | |
| Q3 2023 | +11.1% | -16.7% | +16.7% | |
| Q2 2023 | +75.5% | +128.8% | +181.1% | |
| Q1 2023 | +9.5% | +9.2% | +17.7% | |
| Q4 2022 | -30.4% | -47.5% | -54.9% | |
| Q3 2022 | +7.5% | +0.4% | +20.4% | |
| Q2 2022 | -48.0% | -55.4% | -60.1% | |
| Q1 2022 | -22.3% | -17.8% | -36.3% | |
| Q4 2021 | -44.6% | -37.6% | -7.2% | |
| Q3 2020 | -21.5% | -22.2% | -23.4% | |
| Q3 2021 | -21.9% | -23.2% | -26.6% | |
| Q2 2020 | +7.7% | +9.2% | +7.4% | |
| Q2 2021 | +7.7% | +9.2% | +7.4% | |
| Q1 2020 | +2.7% | +7.7% | +20.3% | |
| Q1 2021 | +7.6% | +10.5% | +23.0% | |
| Q4 2018 | +10.9% | +12.0% | -2.1% | |
| Q4 2019 | +10.9% | +12.0% | -2.1% | |
| Q3 2019 | +10.9% | +12.0% | -2.1% | |
| Q2 2019 | +10.9% | +12.0% | -2.1% | |
| Q4 2020 | +14.2% | +20.1% | +0.3% | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro